πŸ‡ΊπŸ‡Έ FDA
Patent

US 10059713

3-substituted 2-amino-indole derivatives

granted A61KA61K31/437A61K31/4545

Quick answer

US patent 10059713 (3-substituted 2-amino-indole derivatives) held by Takeda Pharmaceutical Company Limited expires Mon Aug 23 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Aug 28 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 23 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61K, A61K31/437, A61K31/4545, A61K31/519, A61K31/5377